MAY 01, 2015 10:10 PM PDT

What if you could create a blood type that worked for any patient?

Donation pathway for ABO blood groups.There are strict rules to blood transfusion. Only blood without A- or B-type antigens, such as type O, can be given to all of those in need. But it's usually in short supply and thousands of patients need it every day.

Those rules may soon change.

As reported in the ACS Journal of the American Chemical Society, a group of scientists have found an efficient way to transform A and B blood into a neutral type that can be given to any patient.

As it stands now, blood transfusions require that the blood type of the donor match that of the recipient. If they don't, there are serious consequences-unless the donor has the blood type O, which can be given to anyone because it doesn't have the A or B antigens that could provoke an immune reaction.

Basically that is because the difference in A, B and O blood types is the presence of slightly different sugar structures on the outside of the red blood cells of each type. Type A and B blood cells each have a single additional sugar attached to their surface.

It makes sense that by removing these sugars, there may be a to convert blood types A and B into type O. And a search for a method to do just that has been going on for some time.

Bacterial enzyme have been identified that can clip the sugars off red blood cells that give blood its "type." But the process isn't efficient enough to give any confident results.

Stephen G Withers and his colleagues wanted to see if they could boost the enzymes' activity. So they did.

By modifying one of those enzymes, they improved its ability to remove type-determining sugars by 170-fold, rendering it antigen-neutral and more likely to be accepted by patients regardless of their blood type.

This discovery could have an impact beyond blood infusion by potentially allowing organ and tissue transplants from donors that would otherwise be mismatched.

The authors acknowledge support from the Canadian Blood Services, the Canadian Institutes of Health Research, Health Canada and the Michael Smith Foundation for Health Research.

Reference:
David H. Kwan, Iren Constantinescu, Rafi Chapanian, Melanie A. Higgins, Miriam P Kötzler, Eric Samain, Alisdair B. Boraston, Jayachandran N. Kizhakkedathu, Stephen G. Withers. Toward Efficient Enzymes for the Generation of Universal Blood through Structure-Guided Directed Evolution. Journal of the American Chemical Society, 2015; 150424072906003 DOI: 10.1021/ja5116088
About the Author
You May Also Like
SEP 17, 2019
Cannabis Sciences
SEP 17, 2019
Can you be Allergic to Cannabis?
Pollen allergies are very common. As cannabis flowers produce, it is also possible to be allergic to cannabis. Here's what to look out for....
SEP 17, 2019
Drug Discovery
SEP 17, 2019
Novel Treatments for Auto-immune Disorders
A recent research study examined a library of almost 300,000 small molecules to search for a molecule that may be a potential target for the human GMP-AMP ...
SEP 17, 2019
Microbiology
SEP 17, 2019
The Right Cocktail of Gut Microbes may Prevent or Reverse Food Allergies
Food allergies are a growing public health concern. New work may help pave the way for a therapeutic that reduces or stops allergies....
SEP 17, 2019
Immunology
SEP 17, 2019
Are Bacteria Fighting Cancer For Us?
Scientists at the Sanford Burnham Prebys Medical Discovery Institute found that the RNF5 enzyme, produced by a gene in gut microbes affects tumor growth.&n...
SEP 17, 2019
Immunology
SEP 17, 2019
AI Not Ready To Predict Acute Kidney Injury
An international group of scientists from the U.S. and U.K. published new research in Nature about the effectiveness of AI in predicting Acute Kidney Injur...
SEP 17, 2019
Drug Discovery
SEP 17, 2019
The Three Drugs that Reverse Biological Aging
In the last 100 years, life expectancy in the US has risen from 55 years until 79 (Roser: 2019). And with the continuous development of medicine and scie...
Loading Comments...